Association of Penicillin Allergy Label With Post‐ COVID ‐19 Condition and Subsequent Clinical Outcomes: A Population‐Based Cohort Study

Key Points

• The study aims to investigate the link between penicillin allergy labeling and the risk of post-COVID-19 condition and related clinical outcomes.
• Conducted a population-based cohort study.
• Analyzed data on individuals with and without penicillin allergy labels.
• Examined the incidence of post-COVID-19 condition and subsequent clinical results.
• Penicillin allergy labeling was associated with a higher risk of post-COVID-19 condition.
• Increased risk of subsequent clinical outcomes was observed in individuals with allergy labels.
• Post-COVID-19 condition did not mediate the link to adverse outcomes.